Relative overhydration is independently associated with left ventricular hypertrophy in dialysis naïve patients with

Byoung-Geun Han1, Jun Young Lee1, Seung Ok Choi1

  • 1Department of Nephrology, Yonsei University Wonju College of Medicine, Kang-won, Wonju, Korea.

Scientific Reports
|October 3, 2020
PubMed

Insights

Fluid overload is linked to left ventricular hypertrophy (LVH) in chronic kidney disease (CKD) patients. Early monitoring of fluid status and cardiac structure is crucial for preventing cardiovascular complications in CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD), worsening with declining kidney function.
  • The complex pathophysiology of LVH in CKD necessitates early risk factor identification and prevention strategies.
  • Managing fluid status is key to minimizing cardiovascular complications like LVH in CKD patients.

Purpose of the Study:

  • To investigate the association between fluid overload and LVH in patients with stage 5 CKD not on dialysis.
  • To identify independent predictors of LVH in this patient population.

Main Methods:

  • Retrospective analysis of a prospective cohort of 205 patients with stage 5 CKD (non-dialysis).
  • Assessment of relative overhydration/extracellular water (OH/ECW) using bioimpedance spectroscopy.
  • Evaluation of associations between fluid balance markers, systolic blood pressure, serum phosphorus, and left ventricular mass index (LVMI).

Main Results:

  • Fluid balance markers were significantly higher in patients with LVH.
  • Increased OH/ECW correlated with higher LVMI.
  • Systolic blood pressure, serum phosphorus, and OH/ECW were independently associated with LVMI.
  • OH/ECW was independently associated with LVH.

Conclusions:

  • Fluid overload, indicated by OH/ECW, is independently associated with LVH in stage 5 CKD patients.
  • Simultaneous cardiac evaluation (echocardiography) and volume status assessment (bioimpedance) are recommended for early-stage CKD patients, even without apparent cardiovascular disease.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
140
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
661
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
502
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
188
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
397
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K